Abstract:Protein nanoparticles (NPs), biocompatible and biodegradable, can be easily surface modified. In particular, amphiphilic proteins act as "surfactants" that help form microparticles while undergoing molecular chain rearrangement. These NPs have been successfully used as drug delivery systems, improving bioavailability and reducing the toxic effects of drug molecules. The use of regenerated silk protein (RSF) with m-acrylamidophenylboronic acid (APBA) composites as drug carriers for loading anti-inflammatory herbal extracts was reported. Firstly, a simple and rapid method was used to prepare silk protein/polyphenylboronic acid nanospheres, in brief, RSF solution and a certain amount of initiator were added to APBA solution, and the pH was adjusted by NaOH, and the polymerization was initiated by heating at 90. under nitrogen protection with stirring at 500 r/min. After 2 h of reaction, a milky solution was obtained, which formed silk protein/benzeneboronic acid nanospheres with hydrophobic interior and hydrophilic surface. The drug-loaded silk protein/polyphenylboronic acid nanospheres with an average size of 550 to 600 nm were prepared by mixing with the drug solution after dialysis and stirring at room temperature for 12 h to load the drug by adsorption. By the same method, drug-loaded albumin/polyphenylboronic acid microspheres and collagen/polyphenylboronic acid microspheres with sizes around 260 nm and 100 nm, respectively, could be prepared. The results observed by scanning and projection electron microscopy and dynamic light scattering showed that the drug-loaded silk protein/polyphenylboronic acid nanomicrospheres displayed regular spherical shape indicating smoothness and good dispersion with no obvious aggregation. The highest drug loading rate was about 13.4%, and the encapsulation rate was over 90%. Also, such drug-loaded nanospheres could achieve controlled release for about seven days and their slow release behavior was pH-responsive, with faster drug release in buffer solution at pH=5.5 than in buffer solution at pH=7.4. In addition, the synergistic interaction of the silk protein/polyphenylboronic acid nanomicrospheres with the subject drug improved its free radical scavenging rate and scavenging efficiency, which was superior to that of the direct drug delivery group. Thus, three protein/polyphenylboronic acid nanomicrospheres with different sizes, electrical properties and drug release rates may be adaptable to a wide range of intravenous and subcutaneous or intraperitoneal drug delivery needs and have great potential for clinical applications.

Polydopamine-Coated Polymer Nanofibers for In Situ Protein Loading and Controlled Release

Preparation of the Protein/Polyphenylboronic Acid Nanospheres for Drug Loading and Unloading

Protein Nanospheres and Nanofibers Prepared by Ice-Templating for the Controlled Release of Hydrophobic Drugs

Polymer-based Nanoparticles for Protein Delivery: Design, Strategies and Applications

Preparation of a Novel Injectable in Situ-Gelling Nanoparticle with Applications in Controlled Protein Release and Cancer Cell Entrapment

Dynamic Covalent Bond-Assisted Programmed And Traceless Protein Release: High Loading Nanogel For Systemic And Cytosolic Delivery

Preparation of drug/polymer fibers in micrometer or nanometer size and their drug release behavior

Poly (N-Isopropylacrylamide)/poly (ethylene Oxide) Blend Nanofibrous Scaffolds: Thermo-responsive Carrier for Controlled Drug Release

Efficient Way to Generate Protein-Based Nanoparticles by In-Situ Photoinitiated Polymerization-Induced Self-Assembly

Versatile Protein Nanogels Prepared by In Situ Polymerization

Dynamic Polymer Amphiphiles for Efficient Intracellular and In Vivo Protein Delivery

Fluoropolymers for intracellular and in vivo protein delivery.

Development of Multinuclear Polymeric Nanoparticles As Robust Protein Nanocarriers.

Controlled Interfacial Polymer Self-Assembly Coordinates Ultrahigh Drug Loading and Zero-Order Release in Particles Prepared under Continuous Flow.

Polymeric Nanoparticles Amenable to Simultaneous Installation of Exterior Targeting and Interior Therapeutic Proteins

Functionalization of Polymers for Intracellular Protein Delivery

Preparing polymer-based sustained-release systems without exposing proteins to water–oil or water–air interfaces and cross-linking reagents

A Light-Activated Polymer with Excellent Serum Tolerance for Intracellular Protein Delivery

Polymers for the sustained release of proteins and other macromolecules

In Situ Polymerization of Zwitterions on Therapeutic Proteins to Enable Their Effective Oral Delivery

A pH-Responsive Phase-Transition Polymer with High Serum Stability in Cytosolic Protein Delivery